KALA BIO, Inc.

NasdaqCM:KALA Stock Report

Market Cap: US$6.1m

KALA BIO Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

David Lazar

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure4.4yrs
Board average tenure8.3yrs

Recent management updates

Recent updates

Kala Pharmaceuticals to execute reverse stock split

Oct 20

Kala Pharmaceuticals Q2 2022 Earnings Preview

Aug 10

CEO

David Lazar (34 yo)

no data
Tenure

Mr. David Elliot Lazar is CEO, CFO & Chairman of Humitech International Group, Inc. and serves as Director. He has been CEO and Chairman of the Company since July 6. 2023. He is Chairman and Chief Executiv...

Leadership Team

NamePositionTenureCompensationOwnership
R. Brazzell
Head of R&D and Chief Medical Officer12.8yrsUS$920.69k0%
$ 0
Todd Bazemore
Principal Executive Officer & Directorless than a yearUS$949.55k0.0019%
$ 113.6
David Lazar
Chairman & CEOno datano datano data
Justin Hanes
Founder & Chair of the Scientific Advisory Boardno datano datano data
Mary Reumuth
CFO, Treasurer & Secretary11.8yrsno data0%
$ 0
Jill Steier
Executive Director of Investor Relations & Corporate Communications4.4yrsno datano data
Vincent Kosewski
Senior VP of Manufacturing & Supply Chain Management8.4yrsno datano data
Darius Kharabi
Chief Business Officer4.1yrsno data0.12%
$ 7.3k
Francis Mah
Chief Medical Advisor2.8yrsno datano data
Josiah Craver
Senior VP & Corporate Controller3.7yrsno datano data
Carl Rennie
Executive Director of Account Management7.6yrsno datano data
Patrick Bedell
Executive Director of Trade & Alternate Channels7.6yrsno datano data
4.4yrs
Average Tenure
52.5yo
Average Age

Experienced Management: KALA's management team is considered experienced (4.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Todd Bazemore
Principal Executive Officer & Directorless than a yearUS$949.55k0.0019%
$ 113.6
David Lazar
Chairman & CEOno datano datano data
Justin Hanes
Founder & Chair of the Scientific Advisory Boardno datano datano data
Jonathan Silverstein
Board Observer9.7yrsno datano data
Peter Hutt
Member of Scientific Advisory Boardno datano datano data
Andrew Koven
Lead Independent Director8.3yrsUS$129.49k0.083%
$ 5.0k
Ronald Krall
Member of Scientific Advisory Boardno datano datano data
Bennett Shapiro
Member of Scientific Advisory Boardno datano datano data
Colin Gardner
Member of Scientific Advisory Boardno datano datano data
Mark Iwicki
Director10.7yrsUS$1.49m0%
$ 0
Howard Rosen
Independent Director & Member of Advisory Board11.9yrsUS$99.74k0.081%
$ 4.9k
Marjan Farid
Independent Director3.2yrsUS$84.85k0.048%
$ 2.9k
8.3yrs
Average Tenure
59yo
Average Age

Experienced Board: KALA's board of directors are considered experienced (8.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/31 11:03
End of Day Share Price 2025/12/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KALA BIO, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
Biren AminJefferies LLC
Christopher NeyorJ.P. Morgan